Tecnoglass Reports Third Quarter 2017 Results
Nov 14, 2017 12:01 pm UTC| Business
- Total Revenues Increase to Record $83.4 Million - - Backlog Expands to Record $488 Million; Up 22% Year-over-Year - Third Quarter 2017 Highlights Total revenues of $83.4 millionThe Company estimates the impact of...
New Frontier Data Partners with Steep Hill
Nov 14, 2017 12:01 pm UTC| Business
Washington, Nov. 14, 2017 -- New Frontier Data, the global cannabis industry authority in intelligence reporting and data analysis, and Steep Hill, the leader in cannabis testing and scientific analytics worldwide,...
INCC engages Buell & Co. to acquire Medical and Recreational Real Estate
Nov 14, 2017 12:01 pm UTC| Business
SARASOTA, Fla. , Nov. 14, 2017 -- International Consolidated Companies, Inc. (OTC:INCC), has engaged, Denver based, Buell Company to locate “Commercial Medical and Recreational Real Estate” properties. Buell ...
Ascendant Resources Announces Fourth Consecutive Month of Positive Adjusted EBITDA in October
Nov 14, 2017 12:01 pm UTC| Business
Adjusted EBITDA1 of $1.3 million in OctoberMilled production increased to 2,184 tpd; up 67% year to dateNew fleet arrivals to drive production growth in Q4 2017 and 2018 TORONTO, Nov. 14, 2017 -- Ascendant...
VirTra Reports Financial Results for Third Quarter of 2017
Nov 14, 2017 12:01 pm UTC| Business
TEMPE, Ariz., Nov. 14, 2017 -- VirTra, Inc. (OTCQX:VTSI), (the “Company”), a global provider of simulators for the law enforcement, military, educational and commercial markets, today announced its financial results for...
Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology
Nov 14, 2017 12:01 pm UTC| Business
CLARKSVILLE, Md., Nov. 14, 2017 -- Neuronascent, Inc. (www.neuronascent.com), a biopharmaceutical company focused on oral therapeutics to promote neuron regeneration, today announced the European Patent Office has...
UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments
Nov 14, 2017 12:01 pm UTC| Business
RA’ANANA, Israel and NEW YORK, Nov. 14, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on...